Price T Rowe Associates Inc Enanta Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $129,509 - $258,434	11,678 New	11,678 $131,000
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $450,661 - $633,735	-11,609 Reduced 6.66%	162,694 $6.58 Million
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $2.71 Million - $3.57 Million	-66,384 Reduced 27.58%	174,303 $8.11 Million
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $2.53 Million - $3.73 Million	52,344 Added 27.79%	240,687 $12.5 Million
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $179,821 - $362,801	-4,716 Reduced 2.44%	188,343 $8.9 Million
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $4.56 Million - $6.02 Million	-81,258 Reduced 29.62%	193,059 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $733,956 - $1.19 Million	12,194 Added 4.65%	274,317 $20.5 Million
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $383,167 - $547,849	9,341 Added 3.7%	262,123 $14.9 Million
Q2 2021 Aug 16, 2021	SELL	$43.76 - $53.11 $26.8 Million - $32.5 Million	-611,479 Reduced 70.75%	252,782 $11.1 Million
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $4.05 Million - $5.34 Million	-97,184 Reduced 10.11%	864,261 $42.6 Million
Q4 2020 Feb 16, 2021	BUY	$41.16 - $47.47 $39.6 Million - $45.6 Million	961,445 New	961,445 $40.5 Million

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.